NIAID Banner Logo Image

HIV Citations List: July, 2022

Literature Citations

1. Design, Synthesis, and Structure-Activity Relationships of Novel 1-(Substituted)-2-methyl-3-(4-oxo-2-methylquinazolin-3(4H)-yl) isothioureas for Their anti-HIV and Antibacterial Activities. Alagarsamy, V., M.T. Sulthana, K. Chitra, V.R. Solomon, and G. Saravanan. Russian Journal of Bioorganic Chemistry, 2022. 48(3): p. 548-556. ISI[000814270800008].
[WOS]. HIV_07_2022.

2. In Vitro Inhibition of HIV-1 by Cyclotide-enriched Extracts of Viola Tricolor. Conzelmann, C., E. Muratspahic, N. Tomasevic, J. Muench, and C.W. Gruber. Frontiers in Pharmacology, 2022. 13: 888961. PMID[35712712]. PMCID[PMC9196940].
[PubMed]. HIV_07_2022.

3. Investigation of Potential Inhibitor Properties of Violacein against HIV-1 RT and CoV-2 Spike RBD:ACE-2. Doganci, M.A., F.A. Sal, H.I. Guler, H. Kati, E. Ceylan, A.O. Belduz, G. Bozdal, N. Yayli, and S. Canakci. World Journal of Microbiology & Biotechnology, 2022. 38(9): 161. PMID[35834025]. PMCID[PMC9281270].
[PubMed]. HIV_07_2022.

4. Repression of HIV-1 Reactivation Mediated by CRISPR/dCas9-KRAB in Lymphoid and Myeloid Cell Models. da Costa, L.C., L.M. Bomfim, U.V.T. Dittz, C.D. Velozo, R.D. da Cunha, and A. Tanuri. Retrovirology, 2022. 19(1): 12. PMID[35733180]. PMCID[PMC9215058].
[PubMed]. HIV_07_2022.

5. Synthesis and anti-HIV Activity of Poly-heterocyclic Compounds Containing Quinoline Moiety. El-Essawy, F.A., N.T.G. Ali, and N.M. Boshta. Russian Journal of General Chemistry, 2022. 92(6): p. 1129-1136. ISI[000821910700026].
[WOS]. HIV_07_2022.

6. Chemical Space Exploration around Indolylarylsulfone Scaffold Led to a Novel Class of Highly Active HIV-1 NNRTIs with Spiro Structural Features. Gao, S., Y. Cheng, S. Song, L. Song, F. Zhao, S. Xu, D. Kang, L. Sun, P. Gao, E. De Clercq, C. Pannecouque, X. Liu, and P. Zhan. European Journal of Medicinal Chemistry, 2022. 238: 114471. PMID[35640327].
[PubMed]. HIV_07_2022.

7. Beyond Inhibition: A Novel Strategy of Targeting HIV-1 Protease to Eliminate Viral Reservoirs. Kim, J.G. and L. Shan. Viruses, 2022. 14(6). PMID[35746649]. PMCID[PMC9231271].
[PubMed]. HIV_07_2022.

8. Synthesis and Evaluation of 1,2,3-Dithiazole Inhibitors of the Nucleocapsid Protein of Feline Immunodeficiency Virus (FIV) as a Model for HIV Infection. Laitinen, T., T. Meili, M. Koyioni, P.A. Koutentis, A. Poso, R. Hofmann-Lehmann, and C.R.M. Asquith. Bioorganic and Medicinal Chemistry 2022. 68: 116834. PMID[35653871].
[PubMed]. HIV_07_2022.

9. Expansion of the S-CN-DABO Scaffold to Exploit the Impact on Inhibitory Activities against the Non-Nucleoside HIV-1 Reverse Transcriptase. Ling, X., Q.Q. Hao, C. Pannecouque, E. Clercq, and F.E. Chen. European Journal of Medicinal Chemistry, 2022. 238: 114512. PMID[35679690].
[PubMed]. HIV_07_2022.

10. Scaffold Modifications to the 4-(4,4-Dimethylpiperidinyl) 2,6-dimethylpyr-idinyl Class of HIV-1 Allosteric Integrase Inhibitors. Parcella, K., M. Patel, Y. Tu, K. Eastman, K. Peese, E. Gillis, M. Belema, I.B. Dicker, B. McAuliffe, B. Ding, P. Falk, J. Simmermacher, D.D. Parker, P. Sivaprakasam, J.A. Khan, K. Kish, H. Lewis, U. Hanumegowda, S. Jenkins, J.F. Kadow, M. Krystal, N.A. Meanwell, and B.N. Naidu. Bioorganic & Medicinal Chemistry, 2022. 67: 116833. PMID[35605346].
[PubMed]. HIV_07_2022.

11. Triazolyl Ru(II), Os(II), and Ir(III) Complexes as Potential HIV-1 Inhibitors. Putterill, B., C. Rono, B. Makhubela, D. Meyer, and N. Gama. BioMetals, 2022. 35(4): p. 771-784. PMID[35699796].
[PubMed]. HIV_07_2022.

12. Polypyridyl Ruthenium Complexes as Bifunctional TAR RNA Binders and HIV-1 Reverse Transcriptase Inhibitors. Wang, M.F., Y. Li, X.D. Bi, Y.X. Guo, M. Liu, H.B. Zhang, and F. Gao. Journal of Inorganic Biochemistry, 2022. 234: 111880. PMID[35679745].
[PubMed]. HIV_07_2022.

Patent Citations

This month, no relevant HIV patents were identified.

If using ChemDB information for publication or abstract presentation, please cite the website in addition to the original information source.    Database last updated: January 2024